Blue Faery Launches Black History Month Event to Address Liver Cancer Disparities in Black Communities

Blue Faery: The Adrienne Wilson Liver Cancer Association will host a free online workshop, Love Your Liver event for Black History Month, on February 5 at 7 PM ET. The event focuses on liver cancer prevention, early detection, and access to care among Black and African American communities, who continue to face disproportionate rates of disease and barriers to treatment. Primary liver cancer is rising steadily in the United States, and Black patients experience earlier onset, higher mortality, and delayed diagnosis compared to other groups. Love Your Liver for Black History Month confronts these inequities by giving attendees practical tools to advocate for screening, lifestyle changes, and medical support before symptoms escalate.

The workshop will feature Dr. Rebecca Jones, Ph.D., Faculty Associate at the Institute for Health Promotion Research at UT Health San Antonio. Dr. Jones will lead an interactive discussion designed to help participants recognize symptoms, understand risk factors, and navigate healthcare systems with confidence. The program invites patients, caregivers, medical professionals, and community leaders to learn how liver cancer affects Black communities and what steps individuals can take to protect themselves and their families. Participants will also receive free educational resources and have the opportunity to submit questions during the live session.

Blue Faery's mission is to prevent, treat, and cure primary liver cancer through research, education, and advocacy. The organization hosts an online Liver Cancer Community for patients and caregivers and provides free comprehensive patient education with its Patient Resource Guides for Liver Cancer. The Love Your Liver Black History Month workshop is free, but registration is required. To learn more, visit Love Your Liver. Blue Faery has many programs including HCC Lunch & Learn, Love Your Liver, The Truth About Liver Cancer, and You and Liver Cancer, all aimed at addressing the growing liver cancer crisis.